1. 심혈관질환 치료 개요
가. 심혈관질환에 대하여 ························································································· 1
1) 심혈관질환의 정의 및 특징 ············································································· 1
2) 심혈관질환 치료의 연구영역 및 기술분류 ···················································· 2
가) 심혈관치료제에 대하여 ··············································································· 3
나) 심혈관 세포치료제에 대하여 ······································································ 5
다) 심장 전기-기계적 기기에 대하여 ····························································· 6
라) 이종장기 심장에 대하여 ············································································· 8

2. 서지분석
가. 특허분석 ·············································································································· 9
1) 해외특허로 살펴본 심혈관질환 치료방법 세계동향 ··································· 10
가) 심혈관치료제 ······························································································ 10
나) 심혈관세포치료제 ······················································································· 16
다) 심장 전기-기계적 기기 ············································································ 22
라) 이종장기 심장 ···························································································· 28
2) 해외에 출원된 특허로 살펴본 심혈관 치료분야 국내동향 ························ 34
3) 한국 특허청에 출원된 특허로 살펴본 심혈관치료분야 국내동향 ············ 37
나. 논문분석 ············································································································ 42
1) 논문으로 살펴본 심혈관치료분야 세계동향 ················································ 43
가) 연도별 추이 ································································································ 43
나) 심혈관치료 분야별 논문 수 ····································································· 44
다) 심혈관치료 분야 논문개제 주요기관 ······················································ 45
라) 심혈관치료 분야 주요 논문 저자 ···························································· 48
마) 심혈관치료 분야 최다 피인용 논문 ························································ 51
바) 심혈관치료 분야 최다 개제 논문 ···························································· 54
사) 심혈관 치료 연구 분야 ············································································· 56

2) 논문으로 살펴본 심혈관치료분야 국내동향 ················································ 57
가) 연도별 추이 ································································································ 57
나) 심혈관치료 분야별 논문 수 ····································································· 58
다) 심혈관치료 분야 논문개재 주요 기관 ···················································· 59
라) 심혈관치료 분야 주요 논문 저자 ···························································· 61
마) 심혈관치료 분야 최다 피인용 논문 ························································ 63
바) 논문발표 주요 저널 ··················································································· 65

3. 시장분석
가. 심혈관질환 환자 현황 ····················································································· 66
나. 시장예측 ············································································································ 70

4. 연구동향
가. 해외의 심혈관 분야 연구 ··············································································· 73
가) 심혈관치료제 ······························································································ 73
나) 세포치료제 ·································································································· 74
다) 심장 전기-기계적 기기 ············································································ 76
라) 이종장기 심장 ···························································································· 77
나. 국내의 심혈관 분야 연구 ··············································································· 78
1) 국내 주요 연구자 및 연구성과 ····································································· 78
가) 합성ㆍ바이오치료제 ··················································································· 78
나) 심혈관줄기세포 치료제 ············································································· 79
다) 심장 전기-기계적 기기 ············································································ 79
라) 이종장기 심장 ···························································································· 80

5. 시사점 및 대응방향
6. 참고문헌